Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness

Pulmonary arterial hypertension (PAH) is commonly treated with pulmonary arteriolar vasodilator therapy. When a patient on PAH medication is admitted to intensive care, determining how to manage their medication during the critical illness is often complicated. There may be considerations related to...

Descripción completa

Detalles Bibliográficos
Autores principales: Muzevich, Katie M, Chohan, Hadi, Grinnan, Daniel C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331447/
https://www.ncbi.nlm.nih.gov/pubmed/25673176
http://dx.doi.org/10.1186/s13054-014-0523-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331447/
https://www.ncbi.nlm.nih.gov/pubmed/25673176
http://dx.doi.org/10.1186/s13054-014-0523-z

Ejemplares similares